Markets Slip as Chips Face Headwinds; Costco Reports Today
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
US Market Highlights
US equity futures are under pressure Wednesday. Treasury Secretary Bessent's comments on Iranian aviation restrictions rattled sentiment. The S&P 500, Nasdaq 100, and Dow Jones futures all opened lower.
MU is the day's most-watched stock. Micron reports Q4 2026 results tonight. A UBS analyst called it a "battleground" between AI momentum and long-term demand concerns. The analyst warned that long-term supply deals could mute revenue upside. Options flow shows heavy negative bets on the stock — up 284% year-to-date, profit-takers are circling.
SNDK dipped in premarket trading despite analysts keeping a positive long-term AI storage view intact. The stock has surged 695% in 2026. Negative options bets are piling in there too.
COST also reports after the close. The $399 billion retailer is one of the most-watched prints this quarter. Short interest sits at just 1.7% of free float — bulls firmly in control heading into the print.
PAYX missed Q2 sales estimates. The payroll firm posted $1.620 billion against a $1.638 billion forecast.
Short Interest Watch
GME short interest spiked to 7.17% of free float from 0.94% just one week ago. That 6.2 percentage point jump signals fresh bearish conviction in the meme stock. Meanwhile, Goldman Sachs reinstated a Buy on MDGL with a $704 target. Quanta Services (PWR) and ABNB both earned analyst upgrades today.
Europe
European markets face spillover pressure from weak US futures. No single large-cap European catalyst dominates today's tape.
Stocks in this article
How this article was generated
- Generated
- 24 Sept 2026, 12:50
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.